RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM
Qian, Y., Hauber, A., Gonzalez, J., Posner, J., Mohamed, A., Tombal, B., Body, JJ., Gatta, F., & Arellano, J. (2014). Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM. Journal of Clinical Oncology, 32(4, Suppl.), Abstract 117.